In vitro stability and metabolism of salvinorin A in rat plasma

被引:48
作者
Tsujikawa, K. [1 ]
Kuwayama, K. [1 ]
Miyaguchi, H. [1 ]
Kanamori, T. [1 ]
Iwata, Y. T. [1 ]
Inoue, H. [1 ]
机构
[1] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan
关键词
Salvinorin A; rat plasma; degradation; carboxylesterase; SALVIA-DIVINORUM; LIQUID-CHROMATOGRAPHY; PARAOXONASE; HYDROLYSIS; AGONIST; SERUM; CARBOXYLESTERASE; HALLUCINOGEN; LACTONASE; ESTERASES;
D O I
10.1080/00498250902769967
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Salvinorin A is the main active psychoactive ingredient in Salvia divinorum, a Mexican plant that has been widely available as a hallucinogen in recent years. The aims of this study were to investigate the stability of salvinorin A in rat plasma, esterases responsible for its degradation, and estimation of the degradation products. The apparent first-order rate constants of salvinorin A at 37C, 25C, and 4C were 3.8 10-1, 1.1 10-1, and 6.0 10-3 h-1, respectively. Salvinorin A degradation was markedly inhibited by the addition of sodium fluoride, an esterase inhibitor. Moreover, phenylmethylsulfonyl fluoride (serine esterase inhibitor) and bis-p-nitrophenyl phosphate (carboxylesterase inhibitor) also inhibited salvinorin A degradation. In contrast, little or no suppression of the degradation was seen with 5,5-dithiobis-2-nitrobenzoic acid (arylesterase inhibitor), ethopropazine (butyrylcholinesterase inhibitor), and BW284c51 (acetylcholineseterase inhibitor). These findings indicated that carboxylesterase was mainly involved in the salvinorin A hydrolysis in rat plasma. The degradation products of salvinorin A estimated by liquid chromatography-mass spectrometry included the deacetylated form (salvinorin B) and the lactone-ring-open forms of salvinorin A and salvinorin B. This lactone-ring-opening reactions were involved in calcium-dependent lactonase.
引用
收藏
页码:391 / 398
页数:8
相关论文
共 19 条
[11]   Determination of Salvinorin A in body fluids by high performance liquid chromatography - Atmospheric pressure chemical ionization [J].
Schmidt, MS ;
Prisinzano, TE ;
Tidgewell, K ;
Harding, W ;
Kreek, MJ ;
Murry, DJ .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 818 (02) :221-225
[12]   SALVIA-DIVINORUM AND SALVINORIN-A - NEW PHARMACOLOGICAL FINDINGS [J].
SIEBERT, DJ .
JOURNAL OF ETHNOPHARMACOLOGY, 1994, 43 (01) :53-56
[13]   Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3 [J].
Teiber, JF ;
Draganov, DI ;
La Du, BN .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (06) :887-896
[14]   A facile method for the preparation of deuterium labeled salvinorin A:: synthesis of [2,2,2-2H3]-salvinorin A [J].
Tidgewell, K ;
Harding, WW ;
Schmidt, M ;
Holden, KG ;
Murry, DJ ;
Prisinzano, TE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (20) :5099-5102
[15]  
Tougou K, 1998, DRUG METAB DISPOS, V26, P355
[16]   CPT-11 CONVERTING ENZYME FROM RAT SERUM - PURIFICATION AND SOME PROPERTIES [J].
TSUJI, T ;
KANEDA, N ;
KADO, K ;
YOKOKURA, T ;
YOSHIMOTO, T ;
TSURU, D .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1991, 14 (06) :341-349
[17]   ETHNOPHARMACOLOGY OF SKA-MARIA-PASTORA (SALVIA, DIVINORUM, EPLING AND JATIVA-M) [J].
VALDES, LJ ;
DIAZ, JL ;
PAUL, AG .
JOURNAL OF ETHNOPHARMACOLOGY, 1983, 7 (03) :287-312
[18]   SALVIA-DIVINORUM AND THE UNIQUE DITERPENE HALLUCINOGEN, SALVINORIN (DIVINORIN)-A [J].
VALDES, LJ .
JOURNAL OF PSYCHOACTIVE DRUGS, 1994, 26 (03) :277-283
[19]  
Yamaori S, 2006, DRUG METAB PHARMACOK, V21, P147, DOI 10.2133/dmpk.21.147